Nihon Rinsho. 2008 Aug;66(8):1591-5.

[Pioglitazone effects on blood pressure in patients with metabolic syndrome].

[Article in Japanese]

Source

Nihon University Health Planning Center, Nihon University School of Medicine.

Abstract

Metabolic syndrome is considered as clustering of cardiovascular risk factors related to insulin resistance. Pioglitazone is one of thiazolidinediones that acts as insulin sensitizer. Since insulin resistance plays a role in pathogenesis of hypertension, pioglitazone may subserve antihypertensive effect in subjects with metabolic syndrome. We reviewed literatures about the effects of pioglitazone on blood pressure. Although blood pressure lowering effect of pioglitazone is small, several clinical trials and a meta-analysis indicated that it decreases both systolic and diastolic blood pressure. Pioglitazone has favorable effects on important components of metabolic syndrome including blood pressure.

PMID:: 18700562; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Medical

Molecular Biology Databases

PIOGLITAZONE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Review [Insulin sensitizer--anti-diabetic drugs, metformin and pioglitazone that can improve insulin resistance]. [Nihon Rinsho. 2006]
Review [Insulin sensitizer--anti-diabetic drugs, metformin and pioglitazone that can improve insulin resistance].
Korenaga M, Kawaguchi K, Korenaga K, Uchida K, Sakaida I. Nihon Rinsho. 2006 Jun; 64(6):1157-64.
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial. [Clin Ther. 2006]
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, et al. Clin Ther. 2006 May; 28(5):679-88.
Review New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer). [Acta Med Indones. 2006]
Review New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A. Acta Med Indones. 2006 Jul-Sep; 38(3):160-6.
Pioglitazone reduces blood pressure in non-dipping diabetic patients. [Minerva Endocrinol. 2004]
Pioglitazone reduces blood pressure in non-dipping diabetic patients.
Negro R, Dazzi D, Hassan H, Pezzarossa A. Minerva Endocrinol. 2004 Mar; 29(1):11-7.
Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus. [Eur J Clin Invest. 2007]
Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.
Anan F, Masaki T, Fukunaga N, Teshima Y, Iwao T, Kaneda K, Umeno Y, Okada K, Wakasugi K, Yonemochi H, et al. Eur J Clin Invest. 2007 Sep; 37(9):709-14.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

[Pioglitazone effects on blood pressure in patients with metabolic syndrome].
[Pioglitazone effects on blood pressure in patients with metabolic syndrome].
Nihon Rinsho. 2008 Aug ;66(8):1591-5.

PubMed
Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double...
Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.
Ann Otol Rhinol Laryngol. 2008 Jul ;117(7):477-83.

PubMed
The biologic effects of implant materials.
The biologic effects of implant materials.
J Orthop Res. 1991 Sep ;9(5):760-75.

PubMed
Decentralization and health resource allocation: a case study at the district le...
Decentralization and health resource allocation: a case study at the district level in Indonesia.
Healthc Q. 2008 ;11(2):117-25.

PubMed
Telemeterized in vivo hip joint force data: a report on two patients after total...
Telemeterized in vivo hip joint force data: a report on two patients after total hip surgery.
J Orthop Res. 1991 Sep ;9(5):621-33.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: